Jia Li

ORCID: 0000-0001-5512-5140
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Extraction and Separation Processes
  • Metal Extraction and Bioleaching
  • High Entropy Alloys Studies
  • Metal and Thin Film Mechanics
  • Advanced materials and composites
  • Lung Cancer Treatments and Mutations
  • High-Temperature Coating Behaviors
  • Diamond and Carbon-based Materials Research
  • Additive Manufacturing Materials and Processes
  • Minerals Flotation and Separation Techniques
  • Cancer Immunotherapy and Biomarkers
  • Aluminum Alloys Composites Properties
  • Aluminum Alloy Microstructure Properties
  • Metal Alloys Wear and Properties
  • Ferroptosis and cancer prognosis
  • Radioactive element chemistry and processing
  • Hydrogen Storage and Materials
  • Electrocatalysts for Energy Conversion
  • Lung Cancer Diagnosis and Treatment
  • Forest, Soil, and Plant Ecology in China
  • Cancer-related molecular mechanisms research
  • Mechanical stress and fatigue analysis
  • Higher Education and Teaching Methods
  • RNA modifications and cancer
  • Metallurgy and Material Forming

Hunan Cancer Hospital
2020-2025

Central South University
2015-2025

State Key Laboratory of Pollution Control and Resource Reuse
2024

Tongji University
2024

Shanghai Institute of Pollution Control and Ecological Security
2024

Minzu University of China
2022-2024

Ministry of Transport
2024

Shanghai Clinical Research Center
2024

Affiliated Hospital of Southwest Medical University
2024

First Affiliated Hospital of Sichuan Medical University
2024

Abstract To investigate the potential mechanisms underlying neutrophil extracellular traps (NETs) confer ferroptosis resistance and CD8(+) T cell inhibition in lung adenocarcinoma (LUAD). By intravenous injection of LLC cells into tail vein, a LUAD mouse model was created. Phorbol‐12‐myristate‐13‐acetate (PMA) stimulated neutrophils to facilitate NETs formation combined with inhibitor DNase I explore mechanism on proliferation, migration, resistance, activity. CitH3, myeloperoxidase (MPO),...

10.1002/ctm2.70192 article EN cc-by Clinical and Translational Medicine 2025-01-26

10.1016/j.ijrmhm.2013.01.020 article EN International Journal of Refractory Metals and Hard Materials 2013-02-15

10.1016/j.ijrmhm.2007.10.003 article EN International Journal of Refractory Metals and Hard Materials 2007-12-04

Dacomitinib is a potent, irreversible and pan-HER tyrosine kinase inhibitor (TKI) of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC). Currently, evidence its activity on brain metastasis lacking.NSCLC patients diagnosed at Hunan Cancer Hospital between July, 2019 2020 with enhanced MRI-detected prior to treatment laboratory-confirmed EGFR mutations were reviewed. In total, 14 EGFR-mutant NSCLC treated first-line dacomitinib. The first radiographic review...

10.1016/j.lungcan.2020.12.008 article EN cc-by-nc-nd Lung Cancer 2020-12-09

Systemic immune-inflammation index (SII), a novel inflammatory marker, has been reported to be associated with diabetic kidney disease (DKD) in the U.S., however, such close relationship DKD other countries, including China, not never determined. We aimed explore association between SII and Chinese population. A total of 1922 hospitalized patients type 2 diabetes mellitus (T2DM) included this cross-sectional study were divided into three groups based on estimated glomerular filtration rate...

10.3389/fendo.2023.1307692 article EN cc-by Frontiers in Endocrinology 2024-01-04
Coming Soon ...